Immune-related adverse events (irAEs) with single-agent PD-1 vs PD-L1 inhibitors: A meta-analysis of 8,730 patients from clinical trials
Year: 2019
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Annals of Oncology
Authors: G.P. Sonpavde, P. Grivas, Y. Lin, D. Hennessy, J.D. Hunt
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2979154844
